Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
1,048 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06781762 | Short-term Impacts of Endocrine Therapy on Cardiovascular and Brain Health Outcomes in Breast Cancer(STRIVE (Acute)) | recruiting | — | 40 | University of TorontoOTHER | 1 | Oct 1, 2025 | clinicaltrials |
| NCT06624930 | Behaviour Change for Cancer Survivors Trial(BOOST-Up) | recruiting | N/A | 236 | University of TorontoOTHER | 1 | Sep 29, 2025 |
| clinicaltrials |
| NCT04258449 | DOvEEgene Fleur: New Uterine Sampling Tool | recruiting | — | 40 | McGill UniversityOTHER | 1 | Sep 26, 2025 | clinicaltrials |
| NCT04814095 | PRecision Oncology Evidence Development in Cancer Treatment - Clinical: PREDiCTc(PREDiCTc) | recruiting | N/A | 30 | British Columbia Cancer AgencyOTHER | 1 | Sep 25, 2025 | clinicaltrials |
| NCT06242912 | Evidence Development in Cancer Treatment - Real World: PREDiCTrw | recruiting | N/A | 100 | British Columbia Cancer AgencyOTHER | 1 | Sep 25, 2025 | clinicaltrials |
| NCT06619769 | eSense-Cancer: Adapting an Online Intervention for Sexual Health Concerns to Gynecologic Cancer(eSense-Cancer) | recruiting | N/A | 60 | University of British ColumbiaOTHER | 1 | Sep 25, 2025 | clinicaltrials |
| NCT06805773 | Evaluating the Use of Educational Videos in Newly Diagnosed Patients in a Medical Oncology Sarcoma Clinic | recruiting | N/A | 100 | Mount Sinai Hospital, CanadaOTHER | 1 | Sep 25, 2025 | clinicaltrials |
| NCT05941507 | A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors | recruiting | Phase 1 / Phase 2 | 300 | LigaChem Biosciences, Inc.INDUSTRY | 2 | Sep 24, 2025 | clinicaltrials |
| NCT06827613 | A Study of Invikafusp Alfa (STAR0602), a Selective T Cell Receptor (TCR)-Targeting, Bifunctional Antibody-fusion Molecule, in Combination With Sacituzumab Govitecan in Participants With Advanced Solid Tumors(START-002) | recruiting | Phase 1 / Phase 2 | 50 | Marengo Therapeutics, Inc.INDUSTRY | 2 | Sep 24, 2025 | clinicaltrials |
| NCT02155621 | Personalized Oncogenomics (POG) Program of British Columbia | recruiting | N/A | 5,000 | British Columbia Cancer AgencyOTHER | 1 | Sep 22, 2025 | clinicaltrials |
| NCT06872840 | Adapting The Fear Of Recurrence Therapy (FORT) for Parents and Establishing Acceptability and Feasibility(Parent-FORT) | recruiting | N/A | 36 | University of OttawaOTHER | 1 | Sep 22, 2025 | clinicaltrials |
| NCT03932786 | Studying Health Outcomes After Treatment in Patients With Retinoblastoma(RIVERBOAT) | recruiting | — | 900 | Vanderbilt-Ingram Cancer CenterOTHER | 2 | Sep 19, 2025 | clinicaltrials |
| NCT06776250 | Study of How Safe and Effective Tarlatamab is in Brain Cancers | recruiting | Phase 2 | 44 | University Health Network, TorontoOTHER | 1 | Sep 19, 2025 | clinicaltrials |
| NCT07180901 | Proactive Risk-based Optimization & Notifications for Treatment & Outcomes in Head & Neck Cancer(PRONTO-HN) | recruiting | N/A | 85 | Centre hospitalier de l'Université de Montréal (CHUM)OTHER | 1 | Sep 18, 2025 | clinicaltrials |
| NCT07179328 | Focused Ultrasound Blood-Brain Barrier Disruption for the Treatment of High-Grade Glioma in Patients Undergoing Standard Chemotherapy | recruiting | Phase 1 | 10 | Sunnybrook Health Sciences CentreOTHER | 1 | Sep 17, 2025 | clinicaltrials |
| NCT06055257 | Combination Therapy: Hyperbaric Oxygen and PENTOCLO for Treatment of Osteoradionecrosis of the Mandible | recruiting | Phase 3 | 24 | Sunnybrook Health Sciences CentreOTHER | 1 | Sep 12, 2025 | clinicaltrials |
| NCT05600400 | Improving Sexual Quality of Life - Randomized Trial of Two vs Five MRI Guided SABR Treatments for Prostate Cancer(iSMART) | recruiting | N/A | 144 | Sunnybrook Health Sciences CentreOTHER | 1 | Sep 9, 2025 | clinicaltrials |
| NCT05786742 | Ultra Hypofractionnated Radiotherapy With HDR Brachytherapy Boost.(HYPO-5) | recruiting | N/A | 205 | CHU de Quebec-Universite LavalOTHER | 1 | Sep 9, 2025 | clinicaltrials |
| NCT06943495 | Personalized vs. Fixed-Activity 177Lu-PSMA-617 Radiopharmaceutical Therapy (PRODIGY-2)(PRODIGY-2) | recruiting | Phase 1 | 60 | Jean-Mathieu BeauregardOTHER | 1 | Sep 9, 2025 | clinicaltrials |
| NCT07162246 | Combined Gamma Knife/Linac Radiosurgery for Large Brain Tumors / Metastases(GK-LIVE) | recruiting | Phase 2 | 60 | Sunnybrook Health Sciences CentreOTHER | 1 | Sep 9, 2025 | clinicaltrials |
| NCT05372354 | A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma | recruiting | Phase 1 / Phase 2 | 260 | Bristol-Myers SquibbINDUSTRY | 5 | Sep 5, 2025 | clinicaltrials |
| NCT06911970 | Impact of Aerobic Exercise on the Anticancer Immune Response in Patients Receiving Cancer Treatment(Immuno-Ex) | recruiting | N/A | 44 | Université de SherbrookeOTHER | 1 | Aug 29, 2025 | clinicaltrials |
| NCT03053193 | MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles(FLEX) | recruiting | — | 30,000 | AgendiaINDUSTRY | 4 | Aug 20, 2025 | clinicaltrials |
| NCT05802121 | Akkermansia Muciniphilia and Metabolic Side Effects of ADT | recruiting | Early Phase 1 | 30 | Western UniversityOTHER | 1 | Aug 20, 2025 | clinicaltrials |
| NCT04429542 | Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors | recruiting | Phase 1 | 292 | Bicara TherapeuticsINDUSTRY | 3 | Aug 15, 2025 | clinicaltrials |
| NCT03765177 | CLIC-1901 for the Treatment of Patients With Relapsed/Refractory CD19 Positive Hematologic Malignancies(CLIC-01) | recruiting | Phase 1 / Phase 2 | 60 | Ottawa Hospital Research InstituteOTHER | 1 | Aug 14, 2025 | clinicaltrials |
| NCT04016389 | FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery | recruiting | N/A | 31 | University Health Network, TorontoOTHER | 2 | Aug 12, 2025 | clinicaltrials |
| NCT03672721 | IA Carboplatin + Radiotherapy in Relapsing GBM | recruiting | Phase 1 / Phase 2 | 35 | Université de SherbrookeOTHER | 1 | Aug 11, 2025 | clinicaltrials |
| NCT06356883 | Intraarterial Carboplatin + Caelyx vs Intraarterial Carboplatin + Etoposide Phosphate for Progressing Glioblastoma | recruiting | Phase 2 | 120 | Université de SherbrookeOTHER | 1 | Aug 7, 2025 | clinicaltrials |
| NCT07104266 | Triple Negative Breast Cancer and Celecoxib. Pilot Study | recruiting | Phase 2 | 30 | Université de SherbrookeOTHER | 1 | Aug 5, 2025 | clinicaltrials |
| NCT04706754 | Pan-Canadian Lung Cancer Observational Study (PALEOS) | recruiting | — | 25,000 | William Osler Health SystemOTHER | 1 | Aug 1, 2025 | clinicaltrials |
| NCT06463340 | Study of SGR-3515 In Participants With Advanced Solid Tumors. | recruiting | Phase 1 | 52 | Schrödinger, Inc.INDUSTRY | 2 | Aug 1, 2025 | clinicaltrials |
| NCT03649048 | Low-Dose Weekly vs High-Dose Cisplatin(RADIO) | recruiting | N/A | 100 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 1 | Jul 31, 2025 | clinicaltrials |
| NCT05733416 | Intensive Cancer Screening After Cryptogenic Stroke(INCOGNITO) | recruiting | N/A | 45 | Ottawa Hospital Research InstituteOTHER | 1 | Jul 31, 2025 | clinicaltrials |
| NCT05820126 | Cold Versus Room Temperature Storage of Platelets for Bleeding in Hematologic Malignancy - a Pilot Trial(CoVeRTS-HM) | recruiting | Phase 2 | 50 | Ottawa Hospital Research InstituteOTHER | 1 | Jul 31, 2025 | clinicaltrials |
| NCT06537154 | NEO-BLAST: Neoadjuvant Therapy for Bladder Cancer Followed by Active Surveillance vs Treatment(NEO-BLAST) | recruiting | Phase 2 / Phase 3 | 688 | Peter BlackOTHER | 1 | Jul 30, 2025 | clinicaltrials |
| NCT06765161 | Efgartigimod in IVIG Dependent Myasthenia Gravis Patients | recruiting | Phase 3 | 30 | Clinique Neuro-OutaouaisOTHER | 1 | Jul 29, 2025 | clinicaltrials |
| NCT05804578 | Using a Blood Test to Monitor Metastatic Breast Cancer Treatment(BEACON) | recruiting | — | 150 | Dr. Christopher MuellerOTHER | 1 | Jul 25, 2025 | clinicaltrials |
| NCT06156800 | Is Radiation-before-pathology a Feasible Approach in the Palliative Oncology Setting? A Pragmatic Clinical Trial(RT-NOW) | recruiting | — | 48 | David PalmaOTHER | 1 | Jul 25, 2025 | clinicaltrials |
| NCT03844399 | (3D) Ultrasound Imaging Liver and Kidney | recruiting | — | 40 | Western University, CanadaOTHER | 1 | Jul 20, 2025 | clinicaltrials |
| NCT04574960 | Neoadjuvant Upper Tract Invasive Cancer Trial (NAUTICAL)(NAUTICAL) | recruiting | Phase 3 | 14 | University Health Network, TorontoOTHER | 1 | Jul 20, 2025 | clinicaltrials |
| NCT06642220 | Ablative Radioembolization of Renal Cell Carcinoma Trial(ARRCC) | recruiting | Phase 2 | 16 | Derek W. CoolOTHER | 1 | Jul 20, 2025 | clinicaltrials |
| NCT06932458 | A Clinical Trial of Primary Retroperitoneal Lymph Node Dissection in Patients With Testicular Seminoma With Limited Retroperitoneal Metastases(RPLND-Seminoma) | recruiting | Phase 2 | 30 | Western University, CanadaOTHER | 1 | Jul 20, 2025 | clinicaltrials |
| NCT05033301 | Evaluating the Effectiveness of the Nurse Ned Clinic(NurseNed) | recruiting | N/A | 600 | University Health Network, TorontoOTHER | 1 | Jul 11, 2025 | clinicaltrials |
| NCT05314400 | Gadoxetate Abbreviated MRI in Metastatic Colorectal Cancer | recruiting | N/A | 200 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 1 | Jul 11, 2025 | clinicaltrials |
| NCT05920343 | VTE Prevention With Rivaroxaban in Genitourinary Cancer Patients Receiving Systemic Therapy(PREVENT-GU) | recruiting | Phase 2 / Phase 3 | 120 | Ottawa Hospital Research InstituteOTHER | 1 | Jul 10, 2025 | clinicaltrials |
| NCT05029063 | Primary Thromboprophylaxis in Patients With Malignancy and Central Venous Catheters(TRIM-Line) | recruiting | Phase 3 | 1,828 | Ottawa Hospital Research InstituteOTHER | 1 | Jul 9, 2025 | clinicaltrials |
| NCT05086692 | A Beta-only IL-2 ImmunoTherapY Study(ABILITY-1) | recruiting | Phase 1 / Phase 2 | 115 | Medicenna Therapeutics, Inc.INDUSTRY | 7 | Jul 9, 2025 | clinicaltrials |
| NCT05830279 | Implementation of Personalized Medicine for Optimal Drug Therapy in Cancer | recruiting | — | 600 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 1 | Jul 9, 2025 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials